Stat5-/- CD4+ T cells elicit anti-melanoma effect by CD4+ T cell remolding and Notch1 activation

Signal transducers and activators of transcription 5 (Stat5) is known to engage in regulating the differentiation and effector function of various subsets of T helper cells. However, how Stat5 regulates the antitumor activity of tumor-infiltrating CD4(+) T cells is largely unknown. Here, we showed that mice with specific deletion of Stat5 in CD4(+) T cells were less susceptible to developing subcutaneous and lung metastatic B16 melanoma with CD4(+) tumor-infiltrating lymphocytes (TIL5) remolding. Especially, we confirmed that Stat5-deficient CD4(+) naive T cells were prone to polarization of two subtypes of Th17 cells: IFN-gamma(+) and IFN-gamma(-) Th17 cells, which exhibited increased anti-melanoma activity through enhanced activation of Notch1 pathway compared with wild type Th17 cells. Our study therefore revealed a novel function of Stat5 in regulating tumor-specific Th17 cell differentiation and function in melanoma. This study also provided a new possibility for targeting Stat5 and other Th17-associated pathways to develop novel immunotherapies for melanoma patients.

Automated summary

This study reveals a novel role of Stat5 in regulating tumor-specific Th17 cell differentiation and function in melanoma, providing new possibilities for developing immunotherapies for melanoma patients.